Organisation/Company: Imperial College
Department: Faculty of Medicine
Research Field: Neurosciences » Neurobiology
Researcher Profile: First Stage Researcher (R1), Recognised Researcher (R2)
Positions: Postdoc Positions
Country: United Kingdom
Application Deadline: 3 Apr 2025 - 23:59 (Europe/London)
Type of Contract: Temporary
Job Status: Full-time
Is the job funded through the EU Research Framework Programme? Not funded by a EU programme
Is the Job related to staff position within a Research Infrastructure? No
The Brancaccio Lab invites applications from talented, highly motivated and creative postdoctoral scientists to take a leading role in one of the following projects investigating molecular cellular and circuit mechanisms driving circadian dysfunction in pre-clinical models of Alzheimer’s disease (AD).
Today, over 1 million people in the UK are living with dementia and related neurodegenerative disorders, such as Alzheimer’s, Parkinson’s, and motor neuron disease (MND). The impact of these incurable and progressive conditions on individuals and their families is devastating. The cost to the economy and public services is large and growing as the UK population ages. However, due to major advances in our understanding of the biology of these diseases, the scientific field is at a tipping point, with the next decade promising to deliver transformative breakthroughs in therapies and a new era of predictive, preventative, and precision medicine for neurodegenerative conditions. The UK is well placed to play a leading role in this revolution due to its scientific strengths in the field, led by the UK Dementia Research Institute (UK DRI) working with our world-class, university-based centres. We are a globally leading multidisciplinary research institute of over 900 staff investigating the spectrum of neurodegenerative disorders causing dementia, driving a step change in our understanding of neurodegeneration, and accelerating the discovery, development and delivery of interventions that will help diagnose, treat, and ultimately prevent dementia. Our principal funder is the Medical Research Council (MRC).
Project: Leveraging circadian clocks to prevent Alzheimer’s disease
In this project, you will develop new molecular tools modifying circadian pathways to prevent/delay Alzheimer’s disease. This project stems from newly established mouse models and clock molecular targets identified in the Brancaccio Lab. You will perform viral delivery of gene therapy viral vectors, behavioural assessment of sleep-wake cycles and cognition, multiplexed live imaging in brain tissue, combinatorial intersectional genetics, and multivariate statistical analysis of time series to validate new chronotherapeutic interventions in Alzheimer’s disease. Further experience with analyses of large ‘OMICS dataset and advanced molecular biology tools in addition to stereotaxic brain surgery and live imaging will be an element of significant strength for this position. Previous knowledge of circadian biology is desirable but not strictly necessary.
Research Field: Biological sciences » Laboratory animal science
Education Level: PhD or equivalent
Research Field: Neurosciences » Neurophysiology
Education Level: PhD or equivalent
* Der Gehaltsbenchmark wird auf Basis der Zielgehälter bei führenden Unternehmen in der jeweiligen Branche ermittelt und dient Premium-Nutzer:innen als Richtlinie zur Bewertung offener Positionen und als Orientierungshilfe bei Gehaltsverhandlungen. Der Gehaltsbenchmark wird nicht direkt vom Unternehmen angegeben. Er kann deutlich über bzw. unter diesem Wert liegen.